Results 111 to 120 of about 184,386 (363)
Stent implantation in a left ventricular assist device
REC: Interventional Cardiology (English Ed.), 2020 Sixty-eight-year-old male patient carrier of one HeartWare left ventricular assist device as destination therapy due to ischemic dilated cardiomyopathy.
Raquel Álvarez Ramos +2 more
doaj +1 more source
Heart Failure Anticoagulation Teach-Back Education and Readmissions [PDF]
, 2020 : Heart failure affects millions of Americans each year. Treatment of advanced heart failure with reduced ejection fraction and left ventricular failure is sometimes treated with implantation of a left-ventricular assist device.
core
Percutaneous Ventricular Assist Devices: New Deus Ex Machina? [PDF]
, 2011 The development of ventricular assist devices has broadened the means with which one can treat acute heart failure. Percutaneous ventricular assist devices (pVAD) have risen from recent technological advances.
Arroyo, Diego, Cook, Stéphane
core +3 more sources
British Journal of Clinical Pharmacology, EarlyView.Objective To determine the optimal anticoagulation intensity of warfarin in a South‐East Asian population with moderate‐to‐severe rheumatic mitral stenosis. Methods A multicentre, retrospective study examined patients with rheumatic mitral stenosis who had not undergone valve replacement or repair and required long‐term warfarin therapy at two ...
Punyawee Puchsaka +6 more
wiley +1 more source
ASAIO Journal, 2019 Neurologic events occur in up to 18% of patients with continuous-flow left ventricular assist devices (LVAD) and is associated with significant morbidity and mortality. The current form of the LVAD equipment is not suited to serve patients who are impaired by a stroke.
Cees W. van der Heiden +6 more
openaire +5 more sources
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim Heart transplantation (HT) is frequently complicated by chronic kidney disease, of which tacrolimus‐related nephrotoxicity is an important cause. In kidney and liver transplant recipients, fast tacrolimus metabolism (defined as a low concentration‐to‐dose [C0/D] ratio), negatively affects kidney function.
Maaike R. Schagen +9 more
wiley +1 more source
Antithrombin Population Pharmacokinetics in Pediatric Ventricular Assist Device Patients. [PDF]
, 2019 OBJECTIVES: Describe the pharmacokinetics of antithrombin in pediatric patients undergoing ventricular assist device therapy and provide dosing recommendations for antithrombin in this population.
Adachi, Iki +6 more
core +1 more source
Synergistic effect of shear and ADP on platelet growth on ZTA and Ti6Al4V surfaces [PDF]
arXiv, 2020 Continuous-flow ventricular assist devices (VADs) have been an increasingly common, life-saving therapy for advanced heart-failure patients, but elevate the risk of thrombosis due to a combination of non-physiological hemodynamics and synthetic biomaterials.
arxiv
Deciphering the skeletal interoceptive circuitry to control bone homeostasis
BMEMat, EarlyView.This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu +7 more
wiley +1 more source
Fungemia Associated with Left Ventricular Assist Device Support [PDF]
, 2009 Objective: Infections remain an important complication of left ventricular assist device (LVAD) support. While relatively uncommon, fungal infections present a serious concern given a high association with adverse events including death.
Bagdasarian, Natasha G. +3 more
core +1 more source